ABSTRACT Previous studies based upon competition between different organic anions for biliary excretion in vivo have suggested that all organic anions share a common hepatic secretory mechanism. Corriedale sheep with an inherited defect in organic anion excretion by the liver were used to study this problem directly without the need for competition studies, the results of which are difficult to analyze. Maximal biliary excretion of sulfobromphthalein (BSP) in mutant Corriedale sheep was less than 7% of that observed in normal sheep whereas maximal biliary excretion of taurocholate, the major organic anion in sheep bile, was not different in mutant and normal sheep. Taurocholate infusion enhanced maximal hepatic excretion of BSP in normal but not in mutant sheep. These studies of an inheritable disorder which appears to be identical to the Dubin-Johnson syndrome in man, demonstrate that taurocholate excretion requires at least one step in biliary excretion which is not required by other organic anions such as bile pigment, porphyrins, drugs, and dyes.
formations. For example, bile salts have been considered to reduce BSP binding to serum albumin (3) and entry into liver cells (3, 6) as well as to enhance BSP excretion in the bile (7) . For these reasons, it has not been clearly demonstrated whether one or more hepatic organic anion secretory mechanisms exist and the relationship between such hepatic mechanisms and the renal organic anion transport system is likewise uncertain.
A unique opportunity to investigate this problem was provided by the discovery of Corriedale sheep with an inherited defect in the biliary excretion of various organic anions including BSP, iopanoic acid, phylloerythrin, conjugated bilirubin, and metanephrine glucuronide (8) (9) (10) . T h e disorder in sheep appears to be functionally and morphologically identical to the DubinJohnson syndrome in man (11).
Sodium taurocholate is the major organic anion in sheep bile (12) . In the present study, the maximal biliary excretion of taurocholate and the effect of intravenous infusion of taurocholate on maximal biliary excretion of BSP were determined in normal and m u t a n t Corriedale sheep.
M A T E R I A L S AND M E T H O D S
Three mutant wethers weighing 13.6-20.2 kg and four normal wethers weighing 13.8-23.5 kg were used in these experiments. Wethers were used as these were the only available mutants with this rare disorder although it is recognized that steroid hormones, particularly estrogens, can affect biliary secretion (13, 14) . The sheep underwent cholecystectomy under full surgical anesthesia and a special T tube (Davol Rubber Co., Oakland, N. J.) with an external diameter of 4 mm and an internal diameter of 3 mrn was inserted into the common bile duct. In the distal limb of the "T," the tube has a small balloon which, following inflation, permits complete collection of bile. With saline irrigation approximately every l0 days, the tube remained in place for from 4 to 14 months and permitted multiple studies in single animals. The external limb of the T tube was occluded except at the time of study. Following surgery, the animals were maintained on hay and goat chow (Purina) for from 3 to 6 wk until the wound healed. The position of the T tube and the completeness of biliary obstruction following inflation of the balloon were demonstrated radiographically following injection of contrast material in the long limb of the tube. The balloon was inflated the night before each experiment and bile was permitted to drain overnight. The animals were placed in a holding stanchion and a polyethylene catheter was inserted into an external jugular vein. In order to establish basal conditions, 5 % dextrose and water was infused intravenously for 1 hr using a Harvard infusion pump following which sodium taurocholate and/or sodium BSP was infused intravenously for 1 hr. The rate of infusion of taurocholate or BSP was changed every 40-60 min at which time bile flow had attained a new steadystate level. When taurocholate and BSP were administered simultaneously, they were infused into separate external jugular veins.
TI~ bile salt used for intravenous infusion was a commercial preparation (California Biochemical Corporation, Los Angeles, Cal.) and bile salt accounted for 80-
92 % of the total solids. Approximately 85-90 % of the bile salt was present as the taurine conjugate of trihydroxy cholanic acid as determined by thin-layer chromatography. The remaining bile salt was present primarily as taurine-conjugated dihydroxy cholanic acid. A 3 % solution was prepared in normal saline immediately before each experiment and passed through a Seitz filter. Taurocholate was also synthesized (15) , had the reported melting point characteristics and migration on thin4ayer chromatograms, and was used in several experiments in normal and mutant sheep. In each experiment bile was collected on ice at 10 min intervals; the volume was measured, and taurocholate and BSP concentrations were estimated (5, 6) . Recovery of taurocholate added to bile averaged 96 4-4.1 (sE) % for 16 determinations in the range of 100 to 900 ~g/ml. Recovery of BSP added to bile averaged 98 4-8 (sE) % for 12 determinations in the range of 25 to 750 #g/ml. In four studies in two normal sheep and in four studies in two mutant sheep, free and conjugated BSP were quantitatively separated in plasma and bile by paper chromatography (16) .
R E S U L T S
In 45 studies in 3 mutant sheep and 52 studies in 4 normal sheep, taurocholate was infused intravenously at increasing rates from 19-305 ~/ m i n . Bile flow increased but was not significantly different between normal and mutant sheep at any infusion rate and reached a maximum of 0.049 4-0.004 ml/min per kg (Table I) . Taurocholate excretion in bile also increased during taurocholate infusion but was not significantly different between normal and mutant sheep at any infusion rate and reached a maximum of 14.2 4-0.8 ~/ m i n per kg (Table II) . The same data presented in Table II are presented in Fig. 1 in which mean biliary taurocholate excretion is plotted against taurocholate infused in the same experiments in normal and mutant sheep. X ~ analysis of the standard error of the means revealed no significant difference in biliary taurocholate excretion between normal and mutant sheep at any taurocholate infusion rate. Further increase in bile salt infusion did not increase, and frequently depressed, bile flow and taurocholate excretion although the animals tolerated large amounts of infused bile salt surprisingly well.
In six studies in four normal sheep and in five studies in three mutant sheep, BSP was infused intravenously at 0.4-0.9 m g / m i n per kg for 1 hr (Table III) . Plasma and biliary dye concentrations were estimated at 10 rain intervals and the volume of bile was recorded. Although plasma BSP levels continued to increase in normal and mutant sheep, BSP excretion in bile in normal sheep reached a mean steady-state level of 0.84 4-0.03 m g / m i n per kg when mean bile flow was 0.044 4-0.012 ml/min per kg. In mutant sheep mean maximal BSP excretion in bile was 0.049 4-0.012 and never exceeded 7 % of that observed in normal sheep whereas mean bile flow was 0.039 4-0.014 ml/min per kg and did not differ significantly from that observed in normal sheep.
In four studies in two mutant sheep and four studies in two normal sheep,
The numbers in parentheses refer to the number of studies performed in each sheep. The weight of each animal increased during the 4-8 month experimental period. Each result is expressed in terms of the appropriate body weight at the time of the particular study. I n calculating the standard error of the mean, each study in each animal was considered as a separate entry. 
BSP was infused during the course of maximal bile secretory response to taurocholate infusion and the biliary excretion of taurocholate and BSP was estimated. Results of a representative experiment are presented in Fig. 2 and data from all experiments are presented in Table IV 
D I S C U S S I O N
Corriedale sheep with inheritable photosensitivity and a black liver have d e f e c t i v e b i l i a r y e x c r e t i o n of a v a r i e t y of o r g a n i c a n i o n s ( 8 -I 0 ) i n c l u d i n g B S P as s h o w n i n T a b l e I I I . D e s p i t e this defect, t h e b i l i a r y e x c r e t i o n of t a u r o c h olate, t h e m a j o r o r g a n i c a n i o n of h u m a n a n d o v i n e bile, d i d n o t differ f r o m t h a t o b s e r v e d i n n o r m a l s h e e p a t all t a u r o c h o l a t e i n f u s i o n rates. A l t h o u g h p l a s m a bile a c i d c o n c e n t r a t i o n s w e r e n o t m e a s u r e d , it is likely t h a t a m a x i m a l , or n e a r maximal, rate of biliary excretion of taurocholate was attained as manifested by the observed changes in bile flow and taurocholate content. Furthermore, increased rates of taurocholate administration usually diminished bile flow and produced clinical toxicity. Therefore, despite a defect in BSP excretion at the level of 7% of normal, taurocholate excretion was unimpaired. Because the mechanism and cellular site of hepatic excretory mechanisms are unknown, only speculation can be offered regarding the locus of the defect in mutant sheep. If one assumes that a series of steps, processes, or carriers may be in-
T A B L E IV E F F E C T OF S O D I U M T A U R O C H O L A T E I N F U S I O N ON BILIARY E X C R E T I O N OF BSP IN N O R M A L AND M U T A N T SHEEP
Four studies were performed in two normal sheep and four studies were performed in two m u t a n t sheep. Results are expressed as m e a n 4-SEM. Details of experiment are provided in text under Methods.
Normal sheep
Mutant sheep M e a n bile flow, ml/min per kg volved in the hepatic excretion of organic anions, then the mutant sheep has a defect in some excretory step which is not required for bile salt excretion. It is theoretically possible that bile salts and other organic anions m a y share some steps or carriers unaffected by the mutation. O'Maille et al. (7) and Gronwall and Cornelius (17) have demonstrated in dog and sheep respectively that BSP excretion in bile is limited by the concentration of BSP in bile and not by a true Tmssr • O'Maille et al. (7) suggest that increased bile flow rate at the canalicular site of BSP excretion produced by bile salt permits an increase in "maximal BSP excretion" to occur without exceeding the limiting biliary dye concentration. This mechanism could be altered membrane permeability, increased dissociation of a carrier: BSP complex at the biliary surface of the cell, or enhanced BSP excretion in a different physical form (i.e., micelle). As anticipated, taurocholate infusion in normal sheep enhanced BSP excretion approximately 230o-/0; however, taurocholate infusion in mutant sheep increased mean BSP excretion by less than 30%. If taurocholate enhances membrane permeability to the dye, carrier :BSP dissociation, or micelle formation, the defect in mutant sheep must occur prior to such steps in the over-all pathway of hepatic excretion of organic anions. The results in mutant sheep indicate that enhanced BSP-micelle formation is unlikely although this was not specifically analyzed.
Neither selective back-diffusion of BSP nor impaired hepatic blood flow is likely to represent the basic defect in the mutant sheep or the response to taurocholate infusion although methods are not available for quantitation of the former process.
Gutstein et al. (18) studied the effect of dehydrocholate infusion on biliary BSP excretion in a human being with the Dubin-Johnson syndrome who had a virtually complete biliary fistula. Impaired biliary excretion of BSP was substantiated by direct measurement in this patient. In addition, dehydrocholate infusion increased bile flow but did not significantly alter biliary BSP excretion. These observations in man are comparable to those reported here in mutant sheep and suggest that hepatic organic anion excretion in man may also represent multiple excretory mechanisms. Plasma bile acid levels are not increased in mutant sheep or in patients with the Dubin-Johnson syndrome t and there are no histologic manifestations of bile secretory failure (cholestasis) (11).
Analysis of BSP conjugates in plasma at the conclusion of BSP infusions revealed that 65 and 70°~ of plasma BSP was conjugated in normai and mutant sheep, respectively. Presumably the excretory mechanism of the liver for the dye was exceeded and BSP is more readily excreted as a conjugate with glutathione than in the free form. Biliary BSP in normal and mutant sheep also revealed a high proportion of conjugated BSP comparable to that observed in other animals (19) . After taurocholate infusion, 82 -4-12% of biliary BSP in normal sheep was conjugated whereas only 59 -4-17% of biliary BSP in mutant sheep was conjugated. This observation suggests some specificity of the excretory mechanism or carrier for conjugated BSP and is in contrast to the suggestion that increase in bile flow rate produced by bile salt administration would enhance the transfer of both conjugated and unchanged BSP from the liver cell into the bile (7).
Studies in progress reveal that mutant sheep have the same renal Trnp~m as normal sheep and, in two experiments, hepatic excretion of an organic cation, procaine amide ethobromide, was not different in normal and mutant sheep. These observations suggest that the renal and hepatic mechanisms for organic anion excretion may differ and that organic anions may be excreted by the liver by different mechanisms than those involved in organic cation excretion. The latter conclusion was initially suggested by the studies of Schanker (20, 21) .
